NF-κB serves as a pivotal regulatory factor in inflammatory responses and a critical therapeutic target for inflammatory diseases, while the PI3K/Akt signaling pathway plays a significant role in promoting the progression of diabetic kidney disease (DKD) (Zhang et al., 2019; En et al., 2021). This evidence concerns the gene NFKB1 and diabetic kidney disease.